ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 10 filers reported holding ASTRAZENECA PLC in Q2 2012. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,004,282 | +68.2% | 12,877 | +46.1% | 0.01% | +60.0% |
Q1 2024 | $597,019 | +10.6% | 8,812 | +9.9% | 0.01% | 0.0% |
Q4 2023 | $539,877 | -17.1% | 8,016 | -16.6% | 0.01% | -28.6% |
Q3 2023 | $650,927 | -12.5% | 9,612 | -7.6% | 0.01% | 0.0% |
Q2 2023 | $744,115 | +19.9% | 10,397 | +16.3% | 0.01% | +16.7% |
Q1 2023 | $620,459 | -0.8% | 8,939 | -3.1% | 0.01% | -14.3% |
Q4 2022 | $625,456 | +24.1% | 9,225 | +0.4% | 0.01% | +16.7% |
Q3 2022 | $504,000 | -13.3% | 9,189 | +4.5% | 0.01% | 0.0% |
Q2 2022 | $581,000 | -2.0% | 8,797 | -1.7% | 0.01% | +20.0% |
Q1 2022 | $593,000 | +42.5% | 8,945 | +25.4% | 0.01% | +25.0% |
Q4 2021 | $416,000 | +66.4% | 7,134 | +71.3% | 0.00% | +100.0% |
Q3 2021 | $250,000 | +16.8% | 4,164 | +16.7% | 0.00% | 0.0% |
Q2 2021 | $214,000 | +2.9% | 3,567 | -14.8% | 0.00% | -33.3% |
Q1 2021 | $208,000 | -3.3% | 4,186 | -2.3% | 0.00% | 0.0% |
Q4 2020 | $215,000 | -33.8% | 4,286 | -27.6% | 0.00% | -40.0% |
Q3 2020 | $325,000 | +1.6% | 5,920 | -2.1% | 0.01% | 0.0% |
Q2 2020 | $320,000 | +16.4% | 6,046 | -1.5% | 0.01% | 0.0% |
Q1 2020 | $275,000 | -20.1% | 6,141 | -11.1% | 0.01% | 0.0% |
Q4 2019 | $344,000 | +88.0% | 6,906 | +67.5% | 0.01% | +66.7% |
Q3 2019 | $183,000 | +10.2% | 4,124 | +2.4% | 0.00% | 0.0% |
Q2 2019 | $166,000 | +9.9% | 4,027 | +7.7% | 0.00% | +50.0% |
Q1 2019 | $151,000 | -16.6% | 3,738 | -21.8% | 0.00% | -33.3% |
Q4 2018 | $181,000 | -14.6% | 4,777 | -10.6% | 0.00% | 0.0% |
Q3 2018 | $212,000 | +87.6% | 5,345 | +66.4% | 0.00% | +50.0% |
Q2 2018 | $113,000 | -4.2% | 3,213 | -5.1% | 0.00% | 0.0% |
Q1 2018 | $118,000 | -12.6% | 3,384 | -12.9% | 0.00% | 0.0% |
Q4 2017 | $135,000 | -11.2% | 3,884 | -13.3% | 0.00% | -33.3% |
Q3 2017 | $152,000 | -18.7% | 4,478 | -18.2% | 0.00% | 0.0% |
Q2 2017 | $187,000 | +105.5% | 5,475 | +88.0% | 0.00% | +50.0% |
Q1 2017 | $91,000 | -72.7% | 2,913 | -76.1% | 0.00% | -66.7% |
Q4 2016 | $333,000 | -27.3% | 12,186 | -12.5% | 0.01% | -33.3% |
Q3 2016 | $458,000 | +573.5% | 13,929 | +520.2% | 0.01% | +350.0% |
Q2 2016 | $68,000 | -81.8% | 2,246 | -58.8% | 0.00% | -77.8% |
Q1 2016 | $373,000 | +38.1% | 5,450 | -31.4% | 0.01% | +28.6% |
Q4 2015 | $270,000 | -17.2% | 7,946 | -22.4% | 0.01% | -22.2% |
Q3 2015 | $326,000 | 0.0% | 10,246 | +100.4% | 0.01% | +12.5% |
Q2 2015 | $326,000 | -12.6% | 5,113 | -6.2% | 0.01% | -11.1% |
Q1 2015 | $373,000 | -27.3% | 5,450 | -25.3% | 0.01% | -25.0% |
Q4 2014 | $513,000 | -85.0% | 7,300 | -84.8% | 0.01% | -82.9% |
Q3 2014 | $3,426,000 | -4.1% | 47,950 | -0.3% | 0.07% | 0.0% |
Q2 2014 | $3,574,000 | -50.2% | 48,100 | -56.5% | 0.07% | -49.3% |
Q1 2014 | $7,176,000 | +1352.6% | 110,600 | +1228.5% | 0.14% | +961.5% |
Q4 2013 | $494,000 | +19.0% | 8,325 | +4.1% | 0.01% | +8.3% |
Q3 2013 | $415,000 | +9.8% | 8,000 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $378,000 | +9.9% | 8,000 | +16.3% | 0.01% | +9.1% |
Q1 2013 | $344,000 | +215.6% | 6,878 | +199.0% | 0.01% | +175.0% |
Q4 2012 | $109,000 | +5.8% | 2,300 | +7.0% | 0.00% | 0.0% |
Q3 2012 | $103,000 | +13.2% | 2,150 | +4.9% | 0.00% | +33.3% |
Q2 2012 | $91,000 | -6.2% | 2,050 | -6.8% | 0.00% | 0.0% |
Q1 2012 | $97,000 | -81.7% | 2,199 | -80.8% | 0.00% | -85.7% |
Q4 2011 | $529,000 | -42.8% | 11,425 | -45.2% | 0.02% | -48.8% |
Q3 2011 | $925,000 | -21.1% | 20,853 | -10.9% | 0.04% | -8.9% |
Q2 2011 | $1,172,000 | +10.6% | 23,413 | +1.9% | 0.04% | +12.5% |
Q1 2011 | $1,060,000 | -18.1% | 22,973 | -18.1% | 0.04% | -21.6% |
Q4 2010 | $1,295,000 | -29.9% | 28,035 | -23.1% | 0.05% | -34.6% |
Q3 2010 | $1,848,000 | +9.3% | 36,443 | +1.6% | 0.08% | -1.3% |
Q2 2010 | $1,691,000 | +21.3% | 35,872 | +15.1% | 0.08% | +38.6% |
Q1 2010 | $1,394,000 | -14.9% | 31,176 | -10.7% | 0.06% | -18.6% |
Q4 2009 | $1,639,000 | +30.2% | 34,912 | +24.7% | 0.07% | +22.8% |
Q3 2009 | $1,259,000 | +6.7% | 27,987 | +4.6% | 0.06% | -5.0% |
Q2 2009 | $1,180,000 | +34.7% | 26,747 | +8.1% | 0.06% | +17.6% |
Q1 2009 | $876,000 | – | 24,733 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |